首页 > 最新文献

Annals of African Medicine最新文献

英文 中文
Role of Maternal Serum Matrix Metalloproteinases and Polymorphisms in Prediction of Preeclampsia. 母体血清基质金属蛋白酶及其多态性在子痫前期预测中的作用。
IF 0.7 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-02-06 DOI: 10.4103/aam.aam_596_25
Mona Asnani, Anjoo Agarwal, Renu Singh, Smriti Agarwal, Nitu Nigam

Background: Significant hemodynamic and uterine changes in normal pregnancy allow adequate uteroplacental blood flow. Matrix metalloproteinases (MMPs) are vital for vascular and uterine remodeling. This study evaluated the role of MMP-9 and MMP-13 levels in predicting Preeclampsia and evaluating different genotypes for MMP-9 and MMP-13 polymorphisms.

Methods: This study was a Prospective Cohort study spanning 18 months, involving 90 pregnant women who attended the antenatal care outpatient department during their first trimester. Participants were selected after excluding those with chronic hypertension or multiple gestations. The study focused on women with singleton pregnancies attending routine visits, and informed consent was obtained prior to recruitment. All standard antenatal investigations and care were provided, and blood samples (10 ml of venous blood) were collected at 11-14 weeks of pregnancy to assess serum levels of metalloproteinases.

Results: A total of 90 first-trimester women to assess the role of MMP-9, 13 levels in predicting preeclampsia, and the influence of gene polymorphism. At 11-14 weeks of pregnancy, blood was drawn from all registered participants for serum levels of metalloproteinases. About 14.4% women developed preeclampsia. Mean MMP-9 was found to be significantly lower in preeclamptic women. MMP-13 was found to be higher in preeclamptic women. However, the Allelic distribution was comparable.

Conclusions: Concluded the possible role of MMPs in predicting preeclampsia. Larger studies, including other metalloproteinases and larger sample sizes, may be planned for the future.

背景:正常妊娠中显著的血流动力学和子宫变化使子宫胎盘血流充足。基质金属蛋白酶(MMPs)对血管和子宫重塑至关重要。本研究评估了MMP-9和MMP-13水平在预测子痫前期的作用,并评估了不同基因型的MMP-9和MMP-13多态性。方法:本研究是一项为期18个月的前瞻性队列研究,涉及90名在妊娠早期参加产前护理门诊的孕妇。在排除了慢性高血压或多胎妊娠的患者后,选择了参与者。该研究的重点是参加常规访问的单胎妊娠妇女,并在招募前获得知情同意。提供所有标准的产前检查和护理,并在妊娠11-14周收集血液样本(10 ml静脉血)以评估血清金属蛋白酶水平。结果:共90例妊娠早期妇女评估mmp - 9,13水平在预测子痫前期的作用,以及基因多态性的影响。在怀孕11-14周时,从所有登记的参与者中抽血检测血清金属蛋白酶水平。大约14.4%的女性患上了先兆子痫。平均MMP-9在子痫前期妇女中明显较低。发现MMP-13在子痫前期妇女中含量更高。然而,等位基因分布具有可比性。结论:结论MMPs在预测子痫前期的可能作用。更大的研究,包括其他金属蛋白酶和更大的样本量,可能计划在未来。
{"title":"Role of Maternal Serum Matrix Metalloproteinases and Polymorphisms in Prediction of Preeclampsia.","authors":"Mona Asnani, Anjoo Agarwal, Renu Singh, Smriti Agarwal, Nitu Nigam","doi":"10.4103/aam.aam_596_25","DOIUrl":"https://doi.org/10.4103/aam.aam_596_25","url":null,"abstract":"<p><strong>Background: </strong>Significant hemodynamic and uterine changes in normal pregnancy allow adequate uteroplacental blood flow. Matrix metalloproteinases (MMPs) are vital for vascular and uterine remodeling. This study evaluated the role of MMP-9 and MMP-13 levels in predicting Preeclampsia and evaluating different genotypes for MMP-9 and MMP-13 polymorphisms.</p><p><strong>Methods: </strong>This study was a Prospective Cohort study spanning 18 months, involving 90 pregnant women who attended the antenatal care outpatient department during their first trimester. Participants were selected after excluding those with chronic hypertension or multiple gestations. The study focused on women with singleton pregnancies attending routine visits, and informed consent was obtained prior to recruitment. All standard antenatal investigations and care were provided, and blood samples (10 ml of venous blood) were collected at 11-14 weeks of pregnancy to assess serum levels of metalloproteinases.</p><p><strong>Results: </strong>A total of 90 first-trimester women to assess the role of MMP-9, 13 levels in predicting preeclampsia, and the influence of gene polymorphism. At 11-14 weeks of pregnancy, blood was drawn from all registered participants for serum levels of metalloproteinases. About 14.4% women developed preeclampsia. Mean MMP-9 was found to be significantly lower in preeclamptic women. MMP-13 was found to be higher in preeclamptic women. However, the Allelic distribution was comparable.</p><p><strong>Conclusions: </strong>Concluded the possible role of MMPs in predicting preeclampsia. Larger studies, including other metalloproteinases and larger sample sizes, may be planned for the future.</p>","PeriodicalId":7938,"journal":{"name":"Annals of African Medicine","volume":" ","pages":""},"PeriodicalIF":0.7,"publicationDate":"2026-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146140903","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Comparative Analysis of the Efficacy of CD117 and Special Stains as Indicators of Mechanical Asphyxial Deaths. CD117与特殊染色作为机械性窒息死亡指标的比较分析。
IF 0.7 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-02-06 DOI: 10.4103/aam.aam_377_25
Raghvendra Singh Shekhawat, Rahul Panwar, Meenakshi Rao, Vikas Premlal Meshram, Meena Suresh Kumar, Sridevi Gnanasekaran, Mohini Rathore, Tanuj Kanchan

Background: Determining the cause of death in suspected asphyxia is often difficult when external findings are absent. Mast cells (MCs) may provide objective histological evidence of hypoxia.

Objective: To compare the efficacy of immunohistochemistry (IHC) using CD117 with Toluidine Blue (TB) and Giemsa (GM) stains in detecting mast cells in asphyxial and non-asphyxial lung tissues.

Materials and methods: Lung samples from 164 medicolegal autopsies at AIIMS Jodhpur were studied, 57 asphyxial and 107 non-asphyxial deaths. Peribronchial and perialveolar regions were examined using TB, GM, and IHC (CD117). Mean mast cell counts were compared using Mann-Whitney U and Kruskal-Wallis tests.

Results: Mast cell counts were significantly higher in asphyxial cases. Peribronchial counts: IHC 2.27 ± 1.02, TB 2.29 ± 1.19, GM 0.84 ± 0.59. Perialveolar counts: IHC 0.74 ± 0.12, TB 0.10 ± 0.19, GM 0.01 ± 0.51. IHC was more sensitive than GM (P < 0.001), while TB showed comparable efficacy to IHC.

Conclusion: CD117-based IHC is the most sensitive method for identifying mast cells in asphyxial lungs, though TB remains a valuable low-cost option. Mast cell analysis can serve as an adjunct marker in diagnosing mechanical asphyxia.

背景:在没有外部检查结果的情况下,确定疑似窒息的死亡原因通常是困难的。肥大细胞(MCs)可能是缺氧的客观组织学证据。目的:比较CD117联合甲苯胺蓝(TB)和吉姆萨(GM)染色免疫组化(IHC)检测窒息性和非窒息性肺组织肥大细胞的效果。材料和方法:研究了焦特布尔医学研究所164例法医尸检的肺样本,其中57例为窒息死亡,107例为非窒息死亡。用TB、GM和免疫组化(CD117)检查支气管周围和肺泡周围区域。使用Mann-Whitney U和Kruskal-Wallis试验比较平均肥大细胞计数。结果:窒息组肥大细胞计数明显增高。支气管周围计数:IHC 2.27±1.02,TB 2.29±1.19,GM 0.84±0.59。肺泡周围计数:IHC 0.74±0.12,TB 0.10±0.19,GM 0.01±0.51。IHC比GM更敏感(P < 0.001),而TB的疗效与IHC相当。结论:基于cd117的免疫免疫反应是鉴定窒息肺肥大细胞最敏感的方法,尽管结核病仍然是一种有价值的低成本选择。肥大细胞分析可作为诊断机械性窒息的辅助标志物。
{"title":"A Comparative Analysis of the Efficacy of CD117 and Special Stains as Indicators of Mechanical Asphyxial Deaths.","authors":"Raghvendra Singh Shekhawat, Rahul Panwar, Meenakshi Rao, Vikas Premlal Meshram, Meena Suresh Kumar, Sridevi Gnanasekaran, Mohini Rathore, Tanuj Kanchan","doi":"10.4103/aam.aam_377_25","DOIUrl":"https://doi.org/10.4103/aam.aam_377_25","url":null,"abstract":"<p><strong>Background: </strong>Determining the cause of death in suspected asphyxia is often difficult when external findings are absent. Mast cells (MCs) may provide objective histological evidence of hypoxia.</p><p><strong>Objective: </strong>To compare the efficacy of immunohistochemistry (IHC) using CD117 with Toluidine Blue (TB) and Giemsa (GM) stains in detecting mast cells in asphyxial and non-asphyxial lung tissues.</p><p><strong>Materials and methods: </strong>Lung samples from 164 medicolegal autopsies at AIIMS Jodhpur were studied, 57 asphyxial and 107 non-asphyxial deaths. Peribronchial and perialveolar regions were examined using TB, GM, and IHC (CD117). Mean mast cell counts were compared using Mann-Whitney U and Kruskal-Wallis tests.</p><p><strong>Results: </strong>Mast cell counts were significantly higher in asphyxial cases. Peribronchial counts: IHC 2.27 ± 1.02, TB 2.29 ± 1.19, GM 0.84 ± 0.59. Perialveolar counts: IHC 0.74 ± 0.12, TB 0.10 ± 0.19, GM 0.01 ± 0.51. IHC was more sensitive than GM (P < 0.001), while TB showed comparable efficacy to IHC.</p><p><strong>Conclusion: </strong>CD117-based IHC is the most sensitive method for identifying mast cells in asphyxial lungs, though TB remains a valuable low-cost option. Mast cell analysis can serve as an adjunct marker in diagnosing mechanical asphyxia.</p>","PeriodicalId":7938,"journal":{"name":"Annals of African Medicine","volume":" ","pages":""},"PeriodicalIF":0.7,"publicationDate":"2026-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146140878","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Post hoc Feasibility Analysis of a Randomized Controlled Trial Comparing Low-dose Aspirin for Preeclampsia Prevention: Implications for Future Trial Design. 一项比较低剂量阿司匹林预防子痫前期的随机对照试验的事后可行性分析:对未来试验设计的启示。
IF 0.7 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-02-06 DOI: 10.4103/aam.aam_487_25
Chandrashekhar Shrivastava, Sarita Rajbhar, Sarita Agrawal, Nilaj Kumar Bagde, Farhat Jahan Khan, Mitul Suhane
<p><strong>Background: </strong>While randomized controlled trials (RCTs) provide critical efficacy data, embedded feasibility analyses are essential for informing the design of larger definitive studies. Although our primary RCT demonstrated preliminary efficacy signals comparing 150 mg versus 75 mg aspirin for preeclampsia prevention, the feasibility of implementing such comparative dose studies in obstetric population remained incompletely characterized.</p><p><strong>Objective: </strong>The objective of this study was to conduct a comprehensive post hoc feasibility analysis of our completed RCT, evaluating key implementation metrics that inform the viability of larger-scale comparative aspirin dose investigations.</p><p><strong>Methods: </strong>We performed a post hoc analysis of feasibility parameters from our double-masked RCT conducted at AIIMS, Raipur (November 2021-November 2022), which randomized 100 high-risk pregnant women to 75 mg (n = 48) versus 150 mg (n = 52) daily aspirin. We retrospectively analyzed predefined feasibility metrics, including recruitment velocity, randomization acceptance rates, intervention adherence, participant retention, outcome assessment completeness, and protocol implementation success. These parameters were evaluated against established benchmarks for obstetric intervention trials.</p><p><strong>Results: </strong>Post hoc feasibility analysis revealed exceptional implementation success across all evaluated domains. Monthly recruitment averaged 8.3 participants (range: 6-12), exceeding typical single-center obstetric trial benchmarks. Randomization acceptance reached 84.7% (100/118 approached participants), demonstrating strong participant willingness to accept dose-comparison randomization. High adherence was observed across both treatment arms, with 94% of participants completing ≥80% of the intended dose. Retention rates were optimal (100% for maternal outcomes and 98% for neonatal outcomes). Complete outcome assessment protocols were successfully implemented with 99% of data completeness. Protocol deviations were minimal (8% minor and 2% major) with no impact on primary feasibility metrics. The embedded feasibility analysis indicates that a definitive, adequately powered trial would be highly feasible, requiring approximately 764 participants based on observed effect sizes (6.9% absolute difference in preeclampsia rates) and variance parameters.</p><p><strong>Conclusion: </strong>This post hoc feasibility analysis of our comparative aspirin dose RCT demonstrates exceptional implementation success, validating the viability of larger definitive trials. The robust recruitment, high acceptance rates, excellent adherence, and complete retention observed provide compelling evidence that multicenter comparative dose trials are feasible and should be prioritized. These findings offer critical implementation guidance for designing adequately powered definitive investigations in this clinically important area.</
背景:虽然随机对照试验(rct)提供了关键的疗效数据,但嵌入的可行性分析对于设计更大规模的确定研究至关重要。虽然我们的初步随机对照试验显示了150mg和75mg阿司匹林预防先兆子痫的初步疗效信号,但在产科人群中实施这种比较剂量研究的可行性仍然不完全确定。目的:本研究的目的是对我们完成的随机对照试验进行全面的事后可行性分析,评估关键实施指标,为大规模比较阿司匹林剂量研究的可行性提供信息。方法:我们对在Raipur AIIMS(2021年11月- 2022年11月)进行的双盲随机对照试验的可行性参数进行了事后分析,该试验将100名高危孕妇随机分为每日服用阿司匹林75 mg (n = 48)和150 mg (n = 52)。我们回顾性分析了预定义的可行性指标,包括招募速度、随机接受率、干预依从性、参与者保留、结果评估完整性和方案实施成功。这些参数是根据既定的产科干预试验基准进行评估的。结果:事后可行性分析揭示了在所有评估领域的卓越实施成功。每月平均招募8.3名参与者(范围:6-12),超过典型的单中心产科试验基准。随机化接受度达到84.7%(100/118位接近的受试者),表明受试者接受剂量比较随机化的意愿很强。两个治疗组均观察到高依从性,94%的参与者完成了≥80%的预期剂量。保留率是最佳的(产妇结局100%,新生儿结局98%)。完整的结果评估方案成功实施,数据完整性达99%。方案偏差最小(8%为小偏差,2%为大偏差),对主要可行性指标没有影响。嵌入的可行性分析表明,根据观察到的效应大小(子痫前期率的绝对差异为6.9%)和方差参数,一项明确的、充分有力的试验将是高度可行的,大约需要764名参与者。结论:我们的比较阿司匹林剂量随机对照试验的事后可行性分析显示了卓越的实施成功,验证了更大规模的确定试验的可行性。稳健的招募、高接受率、优异的依从性和观察到的完全保留提供了令人信服的证据,证明多中心比较剂量试验是可行的,应该优先考虑。这些发现为在这一临床重要领域设计充分有力的明确调查提供了关键的实施指导。
{"title":"Post hoc Feasibility Analysis of a Randomized Controlled Trial Comparing Low-dose Aspirin for Preeclampsia Prevention: Implications for Future Trial Design.","authors":"Chandrashekhar Shrivastava, Sarita Rajbhar, Sarita Agrawal, Nilaj Kumar Bagde, Farhat Jahan Khan, Mitul Suhane","doi":"10.4103/aam.aam_487_25","DOIUrl":"https://doi.org/10.4103/aam.aam_487_25","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;While randomized controlled trials (RCTs) provide critical efficacy data, embedded feasibility analyses are essential for informing the design of larger definitive studies. Although our primary RCT demonstrated preliminary efficacy signals comparing 150 mg versus 75 mg aspirin for preeclampsia prevention, the feasibility of implementing such comparative dose studies in obstetric population remained incompletely characterized.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;The objective of this study was to conduct a comprehensive post hoc feasibility analysis of our completed RCT, evaluating key implementation metrics that inform the viability of larger-scale comparative aspirin dose investigations.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;We performed a post hoc analysis of feasibility parameters from our double-masked RCT conducted at AIIMS, Raipur (November 2021-November 2022), which randomized 100 high-risk pregnant women to 75 mg (n = 48) versus 150 mg (n = 52) daily aspirin. We retrospectively analyzed predefined feasibility metrics, including recruitment velocity, randomization acceptance rates, intervention adherence, participant retention, outcome assessment completeness, and protocol implementation success. These parameters were evaluated against established benchmarks for obstetric intervention trials.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;Post hoc feasibility analysis revealed exceptional implementation success across all evaluated domains. Monthly recruitment averaged 8.3 participants (range: 6-12), exceeding typical single-center obstetric trial benchmarks. Randomization acceptance reached 84.7% (100/118 approached participants), demonstrating strong participant willingness to accept dose-comparison randomization. High adherence was observed across both treatment arms, with 94% of participants completing ≥80% of the intended dose. Retention rates were optimal (100% for maternal outcomes and 98% for neonatal outcomes). Complete outcome assessment protocols were successfully implemented with 99% of data completeness. Protocol deviations were minimal (8% minor and 2% major) with no impact on primary feasibility metrics. The embedded feasibility analysis indicates that a definitive, adequately powered trial would be highly feasible, requiring approximately 764 participants based on observed effect sizes (6.9% absolute difference in preeclampsia rates) and variance parameters.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusion: &lt;/strong&gt;This post hoc feasibility analysis of our comparative aspirin dose RCT demonstrates exceptional implementation success, validating the viability of larger definitive trials. The robust recruitment, high acceptance rates, excellent adherence, and complete retention observed provide compelling evidence that multicenter comparative dose trials are feasible and should be prioritized. These findings offer critical implementation guidance for designing adequately powered definitive investigations in this clinically important area.&lt;/","PeriodicalId":7938,"journal":{"name":"Annals of African Medicine","volume":" ","pages":""},"PeriodicalIF":0.7,"publicationDate":"2026-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146140945","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sociodemographic Determinants of Perception about the Screening of the Adults for Diabetes Mellitus in Saudi Arabia: A Cross-sectional Study. 沙特阿拉伯成人糖尿病筛查感知的社会人口学决定因素:一项横断面研究。
IF 0.7 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-02-06 DOI: 10.4103/aam.aam_503_25
Ibrahim Awad Eljack, Abdullah Hassan Alhalafi, Kamal Eldin Hussein Elhassan, Partha Nandi, Basil Eid H Alosaimi, Emad Abdullah S Alshehri, Ali Mohammed A Alasmari, Abdullah Mohammed M Almarhabi

Background: Type 2 diabetes mellitus (T2DM) is a rapidly growing public health challenge in Saudi Arabia, with early screening being critical for timely intervention. Despite national initiatives, community-based evidence on knowledge, attitudes, and practices (KAP) toward diabetes screening in Bisha province remains scarce.

Objective: This study aimed to assess the KAP regarding type 2 diabetes screening among adults in Bisha province and to explore the influence of sociodemographic characteristics.

Materials and methods: A community-based cross-sectional survey was conducted from January 2023 to December 2023 among 374 adults aged ≥40 years without a prior diagnosis of diabetes. Data were collected using a structured bilingual (English-Arabic) questionnaire covering demographics, knowledge of risk factors and symptoms, and attitudes toward screening. Descriptive analysis and proportions were calculated based on exact frequencies from participant responses.

Results: Overall, 82.1% of respondents had heard about diabetes type 2 screening. Knowledge was variable: 41.7% recognized age ≥40 years as a risk factor, while 59.9% identified family history, 81.0% obesity, and 64.7% lack of exercise. Only 32.4% associated pregnancy with increased risk of T2DM. Regarding awareness of symptoms, it was highest for frequent urination (87.4%), followed by excessive thirst (65.0%), while fewer recognized weight loss (43.6%) and excessive hunger (38.5%). Attitude analysis showed that 63.4% agreed family members of diabetics should be screened, 64.4% endorsed early screening for better disease control, and 61.8% supported universal screening at age 40. A large majority strongly agreed to personal screening if risk factors were present (207 agree, 167 strongly agree) or if overweight/obese (199 agree, 175 strongly agree). Regarding practice-related items, 223 participants agreed and 151 strongly agreed that they would advise others to undergo screening, and over 90% supported screening in high-risk situations such as pregnancy or chronic disease.

Conclusion: The findings reveal high general awareness and favorable attitudes toward diabetes screening among adults in Bisha, although knowledge gaps persist regarding specific risk factors and less obvious symptoms. Targeted education to address these gaps, coupled with reinforcement of screening practices, could enhance community-level prevention strategies in Saudi Arabia.

背景:2型糖尿病(T2DM)在沙特阿拉伯是一个快速增长的公共卫生挑战,早期筛查对于及时干预至关重要。尽管有国家倡议,但在比沙省,关于糖尿病筛查的知识、态度和实践(KAP)的社区证据仍然很少。目的:本研究旨在评估比沙省成人2型糖尿病筛查的KAP,并探讨社会人口学特征的影响。材料和方法:2023年1月至2023年12月,对374名年龄≥40岁、既往未诊断为糖尿病的成年人进行了基于社区的横断面调查。使用结构化双语(英语-阿拉伯语)问卷收集数据,包括人口统计、危险因素和症状的知识以及对筛查的态度。描述性分析和比例是根据参与者回答的确切频率计算的。结果:总体而言,82.1%的受访者听说过2型糖尿病筛查。知识是可变的:41.7%的人认为年龄≥40岁是危险因素,59.9%的人认为家族史,81.0%的人认为肥胖,64.7%的人认为缺乏运动。只有32.4%的人认为怀孕会增加2型糖尿病的风险。在对症状的认识方面,尿频是最高的(87.4%),其次是过度口渴(65.0%),而较少认识到体重减轻(43.6%)和过度饥饿(38.5%)。态度分析显示,63.4%的人同意糖尿病患者的家庭成员应该接受筛查,64.4%的人支持早期筛查以更好地控制疾病,61.8%的人支持在40岁时进行普遍筛查。如果存在风险因素(207人同意,167人强烈同意)或超重/肥胖(199人同意,175人强烈同意),大多数人强烈同意进行个人筛查。关于与实践有关的项目,223名参与者同意,151名参与者强烈同意,他们会建议其他人接受筛查,超过90%的参与者支持在怀孕或慢性病等高风险情况下进行筛查。结论:研究结果显示,尽管对特定危险因素和不太明显症状的知识差距仍然存在,但比沙成年人对糖尿病筛查的普遍认识和态度良好。针对这些差距进行有针对性的教育,再加上加强筛查做法,可以加强沙特阿拉伯的社区一级预防战略。
{"title":"Sociodemographic Determinants of Perception about the Screening of the Adults for Diabetes Mellitus in Saudi Arabia: A Cross-sectional Study.","authors":"Ibrahim Awad Eljack, Abdullah Hassan Alhalafi, Kamal Eldin Hussein Elhassan, Partha Nandi, Basil Eid H Alosaimi, Emad Abdullah S Alshehri, Ali Mohammed A Alasmari, Abdullah Mohammed M Almarhabi","doi":"10.4103/aam.aam_503_25","DOIUrl":"https://doi.org/10.4103/aam.aam_503_25","url":null,"abstract":"<p><strong>Background: </strong>Type 2 diabetes mellitus (T2DM) is a rapidly growing public health challenge in Saudi Arabia, with early screening being critical for timely intervention. Despite national initiatives, community-based evidence on knowledge, attitudes, and practices (KAP) toward diabetes screening in Bisha province remains scarce.</p><p><strong>Objective: </strong>This study aimed to assess the KAP regarding type 2 diabetes screening among adults in Bisha province and to explore the influence of sociodemographic characteristics.</p><p><strong>Materials and methods: </strong>A community-based cross-sectional survey was conducted from January 2023 to December 2023 among 374 adults aged ≥40 years without a prior diagnosis of diabetes. Data were collected using a structured bilingual (English-Arabic) questionnaire covering demographics, knowledge of risk factors and symptoms, and attitudes toward screening. Descriptive analysis and proportions were calculated based on exact frequencies from participant responses.</p><p><strong>Results: </strong>Overall, 82.1% of respondents had heard about diabetes type 2 screening. Knowledge was variable: 41.7% recognized age ≥40 years as a risk factor, while 59.9% identified family history, 81.0% obesity, and 64.7% lack of exercise. Only 32.4% associated pregnancy with increased risk of T2DM. Regarding awareness of symptoms, it was highest for frequent urination (87.4%), followed by excessive thirst (65.0%), while fewer recognized weight loss (43.6%) and excessive hunger (38.5%). Attitude analysis showed that 63.4% agreed family members of diabetics should be screened, 64.4% endorsed early screening for better disease control, and 61.8% supported universal screening at age 40. A large majority strongly agreed to personal screening if risk factors were present (207 agree, 167 strongly agree) or if overweight/obese (199 agree, 175 strongly agree). Regarding practice-related items, 223 participants agreed and 151 strongly agreed that they would advise others to undergo screening, and over 90% supported screening in high-risk situations such as pregnancy or chronic disease.</p><p><strong>Conclusion: </strong>The findings reveal high general awareness and favorable attitudes toward diabetes screening among adults in Bisha, although knowledge gaps persist regarding specific risk factors and less obvious symptoms. Targeted education to address these gaps, coupled with reinforcement of screening practices, could enhance community-level prevention strategies in Saudi Arabia.</p>","PeriodicalId":7938,"journal":{"name":"Annals of African Medicine","volume":" ","pages":""},"PeriodicalIF":0.7,"publicationDate":"2026-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146140607","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Immunomodulatory Effects of Epidural Anesthesia in Patients Undergoing Breast Cancer Surgery. 硬膜外麻醉对乳腺癌手术患者的免疫调节作用。
IF 0.7 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-02-06 DOI: 10.4103/aam.aam_617_25
Nitu Puthenveettil, Sharavanan Raja, Sadhana Ganesan, Sundeep Vijayaraghavan, Sunil Rajan, Jerry Paul

Background: The immune system is suppressed in cancer patients. Identifying the anesthetic procedures that trigger immunomodulation is essential to slow the growth of tumors. Our study's objective was to evaluate how epidural anesthesia affected immunomodulators in individuals having breast cancer surgery.

Methods: Thirty patients undergoing thoracic epidural anesthesia for breast cancer surgery participated in this prospective observational study. Immunomodulator blood samples were taken both before and 2 h after anesthesia.

Results: On comparing interleukin (IL)-1 count before and after epidural anesthesia, there was a statistically significant decrease. On comparing the IL-2, IL-10, and tumor necrosis factor (TNF) before and after epidural anesthesia, there was no change. IL-6 count levels dropped, which was not statistically significant. On comparing the Interferon alpha (IFNα), there was a statistically significant increase. On comparing the leukocyte count before and after epidural anesthesia, there was a rise, which was not statistically significant. On comparing the lymphocyte, eosinophil, basophil, and monocyte count, there was a statistically significant drop. A significant increase in neutrophil count was seen following epidural anesthesia.

Conclusion: IL-1 was significantly reduced, and IFNα was significantly increased during breast cancer procedures conducted under thoracic epidural anesthesia. TNF, IL-2, IL-6, and IL-10 levels were comparable. A considerable increase in neutrophil counts was linked to a significant decrease in lymphocyte, monocyte, eosinophil, and basophil counts, but the overall leukocyte count remained comparable. The possible interaction between anesthesia, the technique of surgery, leukocytes, and cytokine production may have substantial implications during breast cancer surgeries, which needs further evaluation.

背景:癌症患者的免疫系统受到抑制。确定触发免疫调节的麻醉程序对于减缓肿瘤的生长至关重要。我们的研究目的是评估硬膜外麻醉对乳腺癌手术患者免疫调节剂的影响。方法:30例接受胸腔镜硬膜外麻醉的乳腺癌手术患者参与了这项前瞻性观察研究。麻醉前和麻醉后2 h分别取免疫调节剂血样。结果:硬膜外麻醉前后白细胞介素(IL)-1计数比较,差异有统计学意义。比较硬膜外麻醉前后IL-2、IL-10、肿瘤坏死因子(TNF),无明显变化。IL-6计数水平下降,差异无统计学意义。在比较干扰素α (IFNα)时,有统计学意义的增加。硬膜外麻醉前后白细胞计数比较,有升高,但无统计学意义。在比较淋巴细胞、嗜酸性粒细胞、嗜碱性粒细胞和单核细胞计数时,有统计学意义上的显著下降。硬膜外麻醉后中性粒细胞计数明显增加。结论:在胸廓硬膜外麻醉下进行乳腺癌手术时,IL-1明显降低,IFNα明显升高。TNF、IL-2、IL-6和IL-10水平具有可比性。中性粒细胞计数的显著增加与淋巴细胞、单核细胞、嗜酸性粒细胞和嗜碱性粒细胞计数的显著减少有关,但总体白细胞计数保持可比。麻醉、手术技术、白细胞和细胞因子产生之间可能的相互作用可能对乳腺癌手术有重大影响,需要进一步评估。
{"title":"Immunomodulatory Effects of Epidural Anesthesia in Patients Undergoing Breast Cancer Surgery.","authors":"Nitu Puthenveettil, Sharavanan Raja, Sadhana Ganesan, Sundeep Vijayaraghavan, Sunil Rajan, Jerry Paul","doi":"10.4103/aam.aam_617_25","DOIUrl":"https://doi.org/10.4103/aam.aam_617_25","url":null,"abstract":"<p><strong>Background: </strong>The immune system is suppressed in cancer patients. Identifying the anesthetic procedures that trigger immunomodulation is essential to slow the growth of tumors. Our study's objective was to evaluate how epidural anesthesia affected immunomodulators in individuals having breast cancer surgery.</p><p><strong>Methods: </strong>Thirty patients undergoing thoracic epidural anesthesia for breast cancer surgery participated in this prospective observational study. Immunomodulator blood samples were taken both before and 2 h after anesthesia.</p><p><strong>Results: </strong>On comparing interleukin (IL)-1 count before and after epidural anesthesia, there was a statistically significant decrease. On comparing the IL-2, IL-10, and tumor necrosis factor (TNF) before and after epidural anesthesia, there was no change. IL-6 count levels dropped, which was not statistically significant. On comparing the Interferon alpha (IFNα), there was a statistically significant increase. On comparing the leukocyte count before and after epidural anesthesia, there was a rise, which was not statistically significant. On comparing the lymphocyte, eosinophil, basophil, and monocyte count, there was a statistically significant drop. A significant increase in neutrophil count was seen following epidural anesthesia.</p><p><strong>Conclusion: </strong>IL-1 was significantly reduced, and IFNα was significantly increased during breast cancer procedures conducted under thoracic epidural anesthesia. TNF, IL-2, IL-6, and IL-10 levels were comparable. A considerable increase in neutrophil counts was linked to a significant decrease in lymphocyte, monocyte, eosinophil, and basophil counts, but the overall leukocyte count remained comparable. The possible interaction between anesthesia, the technique of surgery, leukocytes, and cytokine production may have substantial implications during breast cancer surgeries, which needs further evaluation.</p>","PeriodicalId":7938,"journal":{"name":"Annals of African Medicine","volume":" ","pages":""},"PeriodicalIF":0.7,"publicationDate":"2026-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146140900","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An Unusual Case of Hypersomnolence. 一个不寻常的嗜睡病例。
IF 0.7 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-02-06 DOI: 10.4103/aam.aam_635_25
Pravin Umakant Naphade, Chintha Sudheendra Lakshman, Satish Nirhale, Prajwal Rao

Abstract: A young woman presented with acute-onset hypersomnia. Due to the acute onset, the possibility of secondary cause was considered. Magnetic resonance imaging of the brain was showing involvement of deep gray structures surrounding the third ventricle such as thalamus, hypothalamus, and caudate nucleus with true diffusion restriction. Differentials of vasculitic infarct or inflammatory cause were considered. Among inflammatory causes, neuromyelitis optica spectrum disorder (NMOSD) was considered due to predominant diencephalic involvement. Serum aquaporin-4 immunoglobulin G was positive. No other NMOSD core criteria fulfilling finding was there. Only hypersomnia presentation of NMOSD is uncommon. It should be considered in an acute hypersomnia patient as it is reversible with effective treatment.

摘要:一位年轻女性表现为急性嗜睡。由于发病急性,考虑了继发原因的可能性。脑磁共振成像显示第三脑室周围的深灰色结构受累,如丘脑、下丘脑和尾状核,弥散受限。考虑血管梗死或炎症原因的鉴别。在炎症原因中,视神经脊髓炎频谱障碍(NMOSD)被认为是由于主要的间脑受累。血清水通道蛋白-4免疫球蛋白G阳性。没有其他符合NMOSD核心标准的发现。只有嗜睡表现的NMOSD是罕见的。在急性嗜睡患者中应该考虑它,因为它是可逆的,有效的治疗。
{"title":"An Unusual Case of Hypersomnolence.","authors":"Pravin Umakant Naphade, Chintha Sudheendra Lakshman, Satish Nirhale, Prajwal Rao","doi":"10.4103/aam.aam_635_25","DOIUrl":"https://doi.org/10.4103/aam.aam_635_25","url":null,"abstract":"<p><strong>Abstract: </strong>A young woman presented with acute-onset hypersomnia. Due to the acute onset, the possibility of secondary cause was considered. Magnetic resonance imaging of the brain was showing involvement of deep gray structures surrounding the third ventricle such as thalamus, hypothalamus, and caudate nucleus with true diffusion restriction. Differentials of vasculitic infarct or inflammatory cause were considered. Among inflammatory causes, neuromyelitis optica spectrum disorder (NMOSD) was considered due to predominant diencephalic involvement. Serum aquaporin-4 immunoglobulin G was positive. No other NMOSD core criteria fulfilling finding was there. Only hypersomnia presentation of NMOSD is uncommon. It should be considered in an acute hypersomnia patient as it is reversible with effective treatment.</p>","PeriodicalId":7938,"journal":{"name":"Annals of African Medicine","volume":" ","pages":""},"PeriodicalIF":0.7,"publicationDate":"2026-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146140964","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluating Predisposition, Infection, Response, and Organ Dysfunction, Acute Physiology and Chronic Health Evaluation, and Sequential Organ Failure Assessment Scores for Mortality Prediction in Geriatric Sepsis: Toward Age-adapted Prognostic Models. 评估易感、感染、反应和器官功能障碍,急性生理和慢性健康评估,顺序器官衰竭评估评分用于老年败血症的死亡率预测:面向年龄适应预后模型。
IF 0.7 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-02-06 DOI: 10.4103/aam.aam_645_25
Anu Gaikwad, Shruti Karnik, Harishchandra Chaudhary

Abstract: Sepsis remains a leading cause of mortality in older adults, whose age-related immune dysfunction, multimorbidity, and frailty complicate both diagnosis and prognostication. Standard scoring systems Predisposition, Infection, Response, and Organ dysfunction (PIRO), Acute Physiology and Chronic Health Evaluation (APACHE), and Sequential Organ Failure Assessment (SOFA) are widely used for risk stratification but were primarily developed in mixed-age populations. Their accuracy and applicability in geriatric sepsis, where physiological reserve and inflammatory response are altered, remain uncertain. To critically review and compare the predictive validity, clinical applicability, and limitations of PIRO, APACHE, and SOFA scoring systems in geriatric sepsis, emphasizing their strengths, weaknesses, and need for adaptation to aging physiology. A comprehensive literature search was conducted across PubMed, Scopus, Web of Science, and Google Scholar. Studies evaluating PIRO, APACHE, or SOFA scores in adults aged ≥60 years with sepsis or septic shock were included. Data regarding discrimination (area under the receiver operating characteristic curve [AUC]), calibration, and clinical outcomes were synthesized narratively. All three models demonstrated moderate-to-good prognostic performance (AUC 0.78-0.86). PIRO exhibited slightly superior individualized prediction by incorporating host and infection variables, whereas APACHE provided robust physiological quantification but tended to overestimate mortality in frail elders. SOFA proved effective for serial monitoring but was limited by baseline organ dysfunction. None fully accounted for frailty or functional decline. While PIRO, APACHE, and SOFA retain prognostic relevance in geriatric sepsis, their predictive precision is reduced by the heterogeneity of aging physiology. Future tools must integrate frailty, multimorbidity, and functional status to achieve truly individualized, age-adapted sepsis prognostication.

摘要:脓毒症仍然是老年人死亡的主要原因,其年龄相关的免疫功能障碍、多病和虚弱使诊断和预后复杂化。标准评分系统易感、感染、反应和器官功能障碍(PIRO)、急性生理和慢性健康评估(APACHE)和顺序器官衰竭评估(SOFA)被广泛用于风险分层,但主要是在混合年龄人群中开发的。他们的准确性和适用性在老年败血症,其中生理储备和炎症反应的改变,仍然不确定。批判性地回顾和比较PIRO、APACHE和SOFA评分系统在老年败血症中的预测有效性、临床适用性和局限性,强调它们的优点、缺点和适应衰老生理的需要。在PubMed、Scopus、Web of Science和b谷歌Scholar上进行了全面的文献检索。对年龄≥60岁的成人脓毒症或感染性休克患者进行PIRO、APACHE或SOFA评分评估的研究纳入其中。有关鉴别(受试者工作特征曲线下面积[AUC])、校准和临床结果的数据进行叙述性综合。所有三种模型均表现出中等至良好的预后表现(AUC 0.78-0.86)。通过纳入宿主和感染变量,PIRO显示出稍微优越的个体化预测,而APACHE提供了稳健的生理量化,但倾向于高估体弱老年人的死亡率。SOFA被证明是有效的连续监测,但受限于基线器官功能障碍。没有一个能完全解释身体虚弱或功能衰退。虽然PIRO、APACHE和SOFA在老年败血症中仍具有预后相关性,但其预测精度因衰老生理学的异质性而降低。未来的工具必须整合虚弱、多病和功能状态,以实现真正个性化、年龄适应的败血症预后。
{"title":"Evaluating Predisposition, Infection, Response, and Organ Dysfunction, Acute Physiology and Chronic Health Evaluation, and Sequential Organ Failure Assessment Scores for Mortality Prediction in Geriatric Sepsis: Toward Age-adapted Prognostic Models.","authors":"Anu Gaikwad, Shruti Karnik, Harishchandra Chaudhary","doi":"10.4103/aam.aam_645_25","DOIUrl":"https://doi.org/10.4103/aam.aam_645_25","url":null,"abstract":"<p><strong>Abstract: </strong>Sepsis remains a leading cause of mortality in older adults, whose age-related immune dysfunction, multimorbidity, and frailty complicate both diagnosis and prognostication. Standard scoring systems Predisposition, Infection, Response, and Organ dysfunction (PIRO), Acute Physiology and Chronic Health Evaluation (APACHE), and Sequential Organ Failure Assessment (SOFA) are widely used for risk stratification but were primarily developed in mixed-age populations. Their accuracy and applicability in geriatric sepsis, where physiological reserve and inflammatory response are altered, remain uncertain. To critically review and compare the predictive validity, clinical applicability, and limitations of PIRO, APACHE, and SOFA scoring systems in geriatric sepsis, emphasizing their strengths, weaknesses, and need for adaptation to aging physiology. A comprehensive literature search was conducted across PubMed, Scopus, Web of Science, and Google Scholar. Studies evaluating PIRO, APACHE, or SOFA scores in adults aged ≥60 years with sepsis or septic shock were included. Data regarding discrimination (area under the receiver operating characteristic curve [AUC]), calibration, and clinical outcomes were synthesized narratively. All three models demonstrated moderate-to-good prognostic performance (AUC 0.78-0.86). PIRO exhibited slightly superior individualized prediction by incorporating host and infection variables, whereas APACHE provided robust physiological quantification but tended to overestimate mortality in frail elders. SOFA proved effective for serial monitoring but was limited by baseline organ dysfunction. None fully accounted for frailty or functional decline. While PIRO, APACHE, and SOFA retain prognostic relevance in geriatric sepsis, their predictive precision is reduced by the heterogeneity of aging physiology. Future tools must integrate frailty, multimorbidity, and functional status to achieve truly individualized, age-adapted sepsis prognostication.</p>","PeriodicalId":7938,"journal":{"name":"Annals of African Medicine","volume":" ","pages":""},"PeriodicalIF":0.7,"publicationDate":"2026-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146140929","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Steroid-induced Hypokalemic Periodic Paralysis. 类固醇引起的低钾性周期性麻痹。
IF 0.7 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-02-06 DOI: 10.4103/aam.aam_531_25
Batchu Nikhita, Nimisha Borra, Rithish Nimmagadda

Abstract: Hypokalemic periodic paralysis (HypoPP) occurs in calcium and sodium ion channelopathy, which is a rare presentation following certain triggers. This typically hereditary condition leads to episodic acute muscle weakness associated with hypokalemia, which can later present as permanent weakness. This article presents the case of a 37-year-old male who developed bilateral lower limb weakness associated with severe hypokalemia following intramuscular administration of 8 mg dexamethasone. HypoPP, though not common, should be evaluated in patients following treatment with glucocorticoids. These patients present with typical symptoms that can be managed accordingly.

摘要:低钾性周期性麻痹(HypoPP)发生于钙钠离子通道病变,是一种罕见的由某些触发因素引起的症状。这种典型的遗传性疾病导致与低钾血症相关的发作性急性肌肉无力,后来可表现为永久性无力。这篇文章提出的情况下,37岁的男性谁发展双下肢无力与严重低钾血症肌肉注射8mg地塞米松。低opp虽然不常见,但在糖皮质激素治疗后的患者中应进行评估。这些患者表现出典型的症状,可以得到相应的治疗。
{"title":"Steroid-induced Hypokalemic Periodic Paralysis.","authors":"Batchu Nikhita, Nimisha Borra, Rithish Nimmagadda","doi":"10.4103/aam.aam_531_25","DOIUrl":"https://doi.org/10.4103/aam.aam_531_25","url":null,"abstract":"<p><strong>Abstract: </strong>Hypokalemic periodic paralysis (HypoPP) occurs in calcium and sodium ion channelopathy, which is a rare presentation following certain triggers. This typically hereditary condition leads to episodic acute muscle weakness associated with hypokalemia, which can later present as permanent weakness. This article presents the case of a 37-year-old male who developed bilateral lower limb weakness associated with severe hypokalemia following intramuscular administration of 8 mg dexamethasone. HypoPP, though not common, should be evaluated in patients following treatment with glucocorticoids. These patients present with typical symptoms that can be managed accordingly.</p>","PeriodicalId":7938,"journal":{"name":"Annals of African Medicine","volume":" ","pages":""},"PeriodicalIF":0.7,"publicationDate":"2026-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146140640","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Profiling High-risk Chronic Obstructive Pulmonary Disease Patients for Triple Therapy: Who Needs It Most? 高危慢性阻塞性肺疾病患者三联治疗分析:谁最需要?
IF 0.7 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-02-06 DOI: 10.4103/aam.aam_514_25
Alfian Nur Rosyid, Arief Bakhtiar, Daniel Maranatha, Muhammad Amin, Arina Dery Puspitasari, Ahmad Mufid Sultoni

Background: Chronic obstructive pulmonary disease (COPD) remains a major contributor to global morbidity and mortality, carrying a substantial clinical and socioeconomic burden. Comprehensive identification of clinical characteristics, biomarkers, and treatment requirements is essential to guide optimal therapeutic strategies. This study aimed to evaluate the clinical determinants associated with the need for triple therapy in COPD patients.

Methods: An analytical observational study with a cross-sectional design was conducted at the Pulmonary Clinic of Universitas Airlangga Hospital. Eligible participants were male patients aged ≥40 years who underwent spirometry and complete clinical evaluation. Patients with incomplete records or concomitant lung diseases were excluded. Clinical data, spirometry, and laboratory results were analyzed using SPSS, with P < 0.05 considered statistically significant.

Results: A total of 50 patients were included. Most were ≥60 years (64%) and severe smokers (74%) with a mean Brinkman index of 827. The majority presented moderate symptom burden according to St. George's Respiratory Questionnaire (SGRQ) (82%), moderate-to-severe functional limitation based on 6-min walk test (60%), and high exacerbation risk (46%). Significant factors associated with the need for triple therapy included blood eosinophil levels (P < 0.001), exacerbation severity (P = 0.001), impaired quality of life (SGRQ, COPD Assessment Test), comorbidity of myocardial infarction, and classification within the Airflow limitation, Burden of symptoms, and Exacerbation risk (ABE) Group.

Conclusion: Triple therapy was predominantly required in patients with eosinophil counts ≥300 cells/μL, a history of severe exacerbations, and those classified as Group E in the ABE group. These patients exhibited poorer quality of life and higher comorbidity burden. The findings align with the WISDOM Trial, underscoring the importance of multidimensional assessment in guiding individualized COPD management.

背景:慢性阻塞性肺疾病(COPD)仍然是全球发病率和死亡率的主要原因,带来了巨大的临床和社会经济负担。全面识别临床特征、生物标志物和治疗要求对于指导最佳治疗策略至关重要。本研究旨在评估与COPD患者需要三联治疗相关的临床决定因素。方法:在埃尔朗加大学医院肺科进行了一项横断面设计的分析性观察研究。符合条件的参与者是年龄≥40岁的男性患者,他们接受了肺活量测定和完整的临床评估。排除记录不完整或伴有肺部疾病的患者。临床资料、肺活量测定及实验室结果采用SPSS分析,P < 0.05为差异有统计学意义。结果:共纳入50例患者。大多数为≥60岁(64%)和重度吸烟者(74%),平均Brinkman指数为827。根据圣乔治呼吸问卷(SGRQ),大多数患者表现为中度症状负担(82%),基于6分钟步行测试的中度至重度功能限制(60%),以及高恶化风险(46%)。与需要三联治疗相关的重要因素包括血中酸性粒细胞水平(P < 0.001)、加重严重程度(P = 0.001)、生活质量受损(SGRQ, COPD评估试验)、心肌梗死合并症,以及气流限制、症状负担和加重风险(ABE)组的分类。结论:ABE组中E组中嗜酸性粒细胞计数≥300细胞/μL、有严重加重史的患者主要需要三联治疗。这些患者表现出较差的生活质量和较高的合并症负担。这些发现与WISDOM试验一致,强调了多维评估在指导个体化COPD管理中的重要性。
{"title":"Profiling High-risk Chronic Obstructive Pulmonary Disease Patients for Triple Therapy: Who Needs It Most?","authors":"Alfian Nur Rosyid, Arief Bakhtiar, Daniel Maranatha, Muhammad Amin, Arina Dery Puspitasari, Ahmad Mufid Sultoni","doi":"10.4103/aam.aam_514_25","DOIUrl":"https://doi.org/10.4103/aam.aam_514_25","url":null,"abstract":"<p><strong>Background: </strong>Chronic obstructive pulmonary disease (COPD) remains a major contributor to global morbidity and mortality, carrying a substantial clinical and socioeconomic burden. Comprehensive identification of clinical characteristics, biomarkers, and treatment requirements is essential to guide optimal therapeutic strategies. This study aimed to evaluate the clinical determinants associated with the need for triple therapy in COPD patients.</p><p><strong>Methods: </strong>An analytical observational study with a cross-sectional design was conducted at the Pulmonary Clinic of Universitas Airlangga Hospital. Eligible participants were male patients aged ≥40 years who underwent spirometry and complete clinical evaluation. Patients with incomplete records or concomitant lung diseases were excluded. Clinical data, spirometry, and laboratory results were analyzed using SPSS, with P < 0.05 considered statistically significant.</p><p><strong>Results: </strong>A total of 50 patients were included. Most were ≥60 years (64%) and severe smokers (74%) with a mean Brinkman index of 827. The majority presented moderate symptom burden according to St. George's Respiratory Questionnaire (SGRQ) (82%), moderate-to-severe functional limitation based on 6-min walk test (60%), and high exacerbation risk (46%). Significant factors associated with the need for triple therapy included blood eosinophil levels (P < 0.001), exacerbation severity (P = 0.001), impaired quality of life (SGRQ, COPD Assessment Test), comorbidity of myocardial infarction, and classification within the Airflow limitation, Burden of symptoms, and Exacerbation risk (ABE) Group.</p><p><strong>Conclusion: </strong>Triple therapy was predominantly required in patients with eosinophil counts ≥300 cells/μL, a history of severe exacerbations, and those classified as Group E in the ABE group. These patients exhibited poorer quality of life and higher comorbidity burden. The findings align with the WISDOM Trial, underscoring the importance of multidimensional assessment in guiding individualized COPD management.</p>","PeriodicalId":7938,"journal":{"name":"Annals of African Medicine","volume":" ","pages":""},"PeriodicalIF":0.7,"publicationDate":"2026-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146140897","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy of Greater Occipital Nerve Block versus Sphenopalatine Ganglion Block for the Treatment of Postdural Puncture Headache after Spinal Anesthesia: A Randomized Clinical Trial. 枕大神经阻滞与蝶腭神经节阻滞治疗脊髓麻醉后硬脊膜穿刺头痛的疗效:一项随机临床试验。
IF 0.7 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-02-06 DOI: 10.4103/aam.aam_376_25
Urvashi Yadav, Shipra Verma, Deepika Doneria, R Hravei

Background: Postdural puncture headache (PDPH) is a common and often debilitating complication following lumbar puncture, affecting approximately 10%-40% of patients. Minimally invasive procedures, such as sphenopalatine ganglion block (SPGB) and greater occipital nerve block (GONB), have shown promising results in the treatment of PDPH. This study aims to compare the efficacy of SPGB and GONB for PDPH and its associated symptoms.

Materials and methods: This study included 64 patients who developed PDPH following spinal anesthesia and were randomized into two equal groups. Group A received bilateral SPGB, whereas Group B received bilateral GONB using 2 mL of 0.5% bupivacaine with 4 mg dexamethasone. Headache was assessed using the Numerical Rating Scale (NRS) at baseline, 30 min, 1 h, 2 h, 6 h, 12 h, 24 h, 48 h, and 1 week postintervention. In addition to pain scores, associated symptoms, need for rescue analgesia, patient satisfaction score, overall treatment outcomes, and adverse effects were recorded and compared.

Result: The supine NRS scores were significantly lower in the GONB group as compared to the SPGB group at 30 min, 1 h and 2 h (P = 0.029, 0.002, and 0.021, respectively). NRS score was significantly lower in the GONB group as compared to the SPGB group at 30 min, 1 h, 2 h, and 6 h (P = 0.006, 0.042, 0.009, and 0.012, respectively) in the sitting position as determined by independent Student's t-test. However, both the treatments showed similar effectiveness after 12 h (P > 0.05). No major adverse effect was observed in both the groups. None of the patients required epidural blood patch in both the groups.

Conclusion: The GONB demonstrated superior efficacy in early headache relief compared to the SPGB in patients with PDPH. However, both the interventions were found to be equally effective in reducing headache intensity and associated symptoms over time, particularly beyond the initial few hours after the procedure.

背景:硬脊膜穿刺后头痛(PDPH)是腰椎穿刺后常见且常使人衰弱的并发症,约影响10%-40%的患者。微创手术,如蝶腭神经节阻滞(SPGB)和大枕神经阻滞(GONB),在治疗PDPH方面显示出有希望的结果。本研究旨在比较SPGB和GONB对PDPH及其相关症状的疗效。材料和方法:本研究纳入64例脊髓麻醉后发生PDPH的患者,随机分为两组。A组给予双侧SPGB, B组给予双侧GONB, 0.5%布比卡因2ml加地塞米松4mg。在干预后基线、30分钟、1小时、2小时、6小时、12小时、24小时、48小时和1周,采用数值评定量表(NRS)对头痛进行评估。除疼痛评分外,还记录并比较相关症状、抢救性镇痛需求、患者满意度评分、总体治疗结果和不良反应。结果:GONB组30 min、1 h、2 h仰卧位NRS评分显著低于SPGB组(P值分别为0.029、0.002、0.021)。经独立学生t检验,GONB组在坐姿30 min、1 h、2 h、6 h的NRS评分显著低于SPGB组(P分别为0.006、0.042、0.009、0.012)。12 h后两组疗效相近(P < 0.05)。两组均未观察到重大不良反应。两组患者均不需要硬膜外补血。结论:与SPGB相比,GONB对PDPH患者早期头痛的缓解效果更好。然而,随着时间的推移,这两种干预措施在减轻头痛强度和相关症状方面同样有效,特别是在手术后最初的几个小时之后。
{"title":"Efficacy of Greater Occipital Nerve Block versus Sphenopalatine Ganglion Block for the Treatment of Postdural Puncture Headache after Spinal Anesthesia: A Randomized Clinical Trial.","authors":"Urvashi Yadav, Shipra Verma, Deepika Doneria, R Hravei","doi":"10.4103/aam.aam_376_25","DOIUrl":"https://doi.org/10.4103/aam.aam_376_25","url":null,"abstract":"<p><strong>Background: </strong>Postdural puncture headache (PDPH) is a common and often debilitating complication following lumbar puncture, affecting approximately 10%-40% of patients. Minimally invasive procedures, such as sphenopalatine ganglion block (SPGB) and greater occipital nerve block (GONB), have shown promising results in the treatment of PDPH. This study aims to compare the efficacy of SPGB and GONB for PDPH and its associated symptoms.</p><p><strong>Materials and methods: </strong>This study included 64 patients who developed PDPH following spinal anesthesia and were randomized into two equal groups. Group A received bilateral SPGB, whereas Group B received bilateral GONB using 2 mL of 0.5% bupivacaine with 4 mg dexamethasone. Headache was assessed using the Numerical Rating Scale (NRS) at baseline, 30 min, 1 h, 2 h, 6 h, 12 h, 24 h, 48 h, and 1 week postintervention. In addition to pain scores, associated symptoms, need for rescue analgesia, patient satisfaction score, overall treatment outcomes, and adverse effects were recorded and compared.</p><p><strong>Result: </strong>The supine NRS scores were significantly lower in the GONB group as compared to the SPGB group at 30 min, 1 h and 2 h (P = 0.029, 0.002, and 0.021, respectively). NRS score was significantly lower in the GONB group as compared to the SPGB group at 30 min, 1 h, 2 h, and 6 h (P = 0.006, 0.042, 0.009, and 0.012, respectively) in the sitting position as determined by independent Student's t-test. However, both the treatments showed similar effectiveness after 12 h (P > 0.05). No major adverse effect was observed in both the groups. None of the patients required epidural blood patch in both the groups.</p><p><strong>Conclusion: </strong>The GONB demonstrated superior efficacy in early headache relief compared to the SPGB in patients with PDPH. However, both the interventions were found to be equally effective in reducing headache intensity and associated symptoms over time, particularly beyond the initial few hours after the procedure.</p>","PeriodicalId":7938,"journal":{"name":"Annals of African Medicine","volume":" ","pages":""},"PeriodicalIF":0.7,"publicationDate":"2026-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146140953","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Annals of African Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1